S-4664-119
Read twice and referred to the Committee on Environment and Public Works.
Sponsored by Christopher Coons (D-DE)
What it does
This bill would formally authorize the EPA's existing Safer Choice Program, which certifies consumer and institutional products whose chemical ingredients meet science-based safety standards for human health and the environment. It would codify program procedures, allow the use of qualified third-party reviewers to evaluate products, require full ingredient disclosure as a condition of certification, and authorize $6 million per year from fiscal years 2028 through 2034. Participation by manufacturers would remain entirely voluntary.
Who benefits
Consumers who want reliable information about the chemical safety of cleaning and household products. Manufacturers — especially small and medium-sized businesses — that have already invested in meeting Safer Choice standards and would gain greater program stability and continuity. Retailers and institutional purchasers (hospitals, schools, government agencies) that use the label to guide procurement decisions. Third-party chemical profiling firms that would gain a formal role in the certification process. Environmental and public health organizations that support ingredient transparency.
Who is hurt
Manufacturers of competing products that do not carry the Safer Choice label, who may face indirect market disadvantage as the label gains greater visibility and credibility. Chemical suppliers whose ingredients do not meet the Safer Choice standard and could be excluded from certified products. Taxpayers who would fund the $6 million annual appropriation. Manufacturers who currently participate informally and may face more structured compliance and disclosure requirements under the codified program.
Supporters argue
Supporters argue that the Safer Choice Program has operated successfully for over a decade without a formal statutory foundation, leaving it vulnerable to administrative discontinuation and creating uncertainty for the thousands of manufacturers who have invested in meeting its standards. They contend that codifying the program preserves a proven, market-based, non-regulatory tool that drives safer chemistry innovation without mandating anything — giving businesses a predictable framework and consumers a trustworthy label backed by rigorous, science-based review.
Opponents argue
Opponents argue that formally authorizing and funding the program effectively puts the federal government's thumb on the scale in favor of certain chemical products over others, distorting market competition with taxpayer dollars. They contend that the bill's full ingredient disclosure requirements and the EPA's authority to expand eligible product categories and update standards over time could gradually expand the program's reach and regulatory footprint beyond its current voluntary scope, creating de facto compliance pressure on manufacturers who fear market disadvantage without the label.
Constitutional context
The bill operates under Congress's Commerce Clause authority (Art. I, §8, cl. 3), which provides the basis for federal regulation of chemical products in interstate commerce. Because the program is voluntary and does not impose mandates, it raises fewer constitutional concerns than regulatory programs. However, post-Loper Bright (2024), any future EPA rulemaking to expand standards or product categories would face independent judicial scrutiny rather than deference, and the major questions doctrine from West Virginia v. EPA (2022) could apply if the EPA attempted sweeping expansions of program scope beyond what Congress clearly authorized here.
Checks and balances
The EPA Administrator gains formal statutory authority to run, expand, and update the Safer Choice Program; Congress checks this through the annual appropriations process, annual reporting requirements, and the bill's explicit limitation that the program remain voluntary and non-regulatory.
Historical precedent
The Energy Star program, jointly administered by EPA and DOE since 1992, provides a direct analogue — a voluntary, government-backed product certification label that operates through market incentives rather than mandates and has been periodically reauthorized by Congress.